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Tumor immunity has been attributed to incompatibility between tumor
antigens and the host. This incompatibility is due to strain-specific tumor antigens,
as well as tumor-specific antigens. These antigens are unstable in some cases and
undetectable after several generations of transplantation (1) or after storage of the
tumors at low temperature (2).
There are, at present, a few established tumors in this category; e.g., Ehrlich
ascites tumor, which is not only lethal to all strains of mice, but also transplantable
in rate for many generations (3). Furthermore, induction of immunity against a
spontaneous tumor is difficult to achieve in animals of the strain in which the tumor
onginates. This is because the antigens that these tumors contain, although strain-
specific, are not tumor-specific. In the case of the Ehrlich tumor, even the iso-
antigens appear to be destroyed or masked in transplantation, so that many efforts
have been unsuccessful in the induction of immunity to this tumor.
Recently there have been two reports of the successful development of immunity
after treatment of mice with X-irradiated tumor cells (4, 5). The immunity
appeared to be more definite in Swiss mice than in the C57BL strain, indicating
possible influence of isoantigens of the treated tumor cells in the induction of im-
munity in the recipients, as genetic purity is not characteristic of Swiss mice.
The experiments reported in the present paper were carried out in order to
detect any role that isoantigens may play in immunity to the Ehrlich tumor, and to
determine whether the effects of sonic vibrations on tumor cells are similar to those
of X radiation. Mice at differing age levels were used in order to reveal effects of
age on the pathogenicity of the tumor and on the acquisition of immunity.
* This study was carried out at the Dept. of Medical Microbiology, Stanford University, in
1962, being supported by Training Grant ZE-82, U.S. Public Health Service.
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Two strains of mice, CFl and C57BLjKa, were used in the experiments. The
former are a stock of Swiss mice bred in this laboratory for many years. The latter
were kindly offered by Dr. H. Kaplan's laboratory.
The Ehrlich ascites tumor has been propagated in CFl mice at this laboratory
for several years. Tumor cells removed from fresh ascites of tumor-bearing mice
were centrifuged at 600 g several times, and were then resuspended in a 5-fold
volume of Tryode's solution. Finally the cell suspension was put into plastic tubes
and was subjected to sonic vibration at 10 KG, 1.5 A, 6 to 8 times, for I-minute
periods with 4-minute intervals.
The sonized cell suspensions were injected intravenously or intraperitoneally
into mice at various ages (Table 1). The intravenous injections were performed in
newborn mice through an orbital branch of the anterior facial vein (6), in sucklings
through the femoral vein, and in adults through the caudal vein.
Lymphoid cells teased from spleens and lymph nodes of normal adult GF I mice
were prepared for the immunization of animals in the same manner, but without the
use of sonic vibration.
The mice pretreated with a single application of these materials were challenged
with an intraperitoneal injection of Ehrlich tumor cells 4 weeks after the immuniz-
ation. The animals surviving from the first challenge were tested for immunity again
by second and third injections, at 4-week intervals. So that the pathogenicity of
the tumor cells would be the same for every challenge, fresh ascites diluted 1 :3 with
Tyrode's solution was separately poured into more than 100 tubes and kept at
-70o G. with dry ice, and 0.2 ml of ascites restored from this stock was injected in-
traperitoneally into every mouse, whether immunized or control.
For histological examination, suitable organs were removed at autopsy from
the mice killed by the tumor. After fixation of the organs with formalin, the tis-
sues were sectioned in paraffin blocks and stained with hematoxylin and eosin.
RESULTS
Pathogenicity of the fresh or restored tumor cells to mice at various
ages.
All adult mice were killed by progressive ascites tumor, with an average sur-
vival time of 17.5 days after intraperitoneal injection of resh tumor cells. Restored
cells showed almost the same pathogenic activity as did fresh cells. The slight
difference in activity between these two types of cells, as shown in Table 1, might be
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Table I. Treatment of.Mice at Various Ages with Fresh or Sonized Ehrlich Tumor Cells.
Age at I Injected
I









of Amount No. of survival diseasetreatment material inject. (ml) mice deaths (days) :jj: surviving
Adult Fresh E.C. IV 0.1 22
I
0 - - 22
" " " ip 0.1 20 20 17.4 A 0
" Restored " ip 0.1 20 20 16.5 A 0
Suckling Fresh " IV 0.03 14 10 19.4 L 4
" " " ip 0.03 10 10 14.0 A 0
Newborn " " IV 0.01 18 18 12.3 L* 0
" " " ip 0.01 20 20 11.3 L 0
Adult Sonized E.C. ip 0.5 28 6 20.3 A 22
Suckling " " ip 0.2 15 13 15.2 A 2
2-3 days " " IV 0.1 28 25 0.5 S 3
" " " " ip 0.1 32 16 11.7 L+A** 16
12 hrs " " IV 0.05 67 67 0.5 S 0
" " "
II ip 0.05 66 40 11.7 L** 26
I
:jj: A (ascites tumor), L (lung tumor), S (shock).
* Many of the mice also developed subcutaneous tumors at the site of injection.
* * Some of the mice died from shock.
due to differences in the sources of the ascites and in the numbers of active tumor
cells.
The Injection appeared to be more intensively toxic to newborn mIce. The
average survival after treatment was 11.3 days for newborn, but 17.4 days for
adults. The contrast is significant, especially since the number of tumor cells
injected into newborn was smaller, being in proportion to body weight. The
difference in the histological findings was even more significant. Examination of
the newborn at autopsy showed abundant tumors in the lung. There were no
macroscopic lesions outside the lung, but histological examination demonstrated
invasion of tumor cells into the peritoneum, pancreas, liver, and kidneys. Intra-
venous injection offresh tumor cells into adult mice did not result in either symptoms
of illness or microscopically demonstrable lesions, but was occasionally followed by
the development of small subcutaneous indurations at the site of injection. A simi-
lar injection of a reduced amount of tumor cells into newborn resulted in all treated
animals dying from lung tumors. Besides the lung tumors, small invasions of tumor
cells were demonstrated microscopically in the liver and kidneys.
The pathogenicity of the tumor to suckling mice was intermediate betwecd
that to adult and newborn. Average survival time of mice receiving the tumor at
ages of 12 to 14 days were 14.0 days after intraperitoneal injection and 19.4 days after
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intravenous injection. Intraperitoneal injection was followed by death from pro-
gressive ascites, and intravenous injection by death from lung tumors. Large
tumors were also produced at the site of the intravenous injection, but histological
examination showed that it was the lung tumors that were responsible for the death
of the mice.
In these experiments, young mice appeared to be more sensitive than old mice
to the Ehrlich tumor, and mice of any age were more sensitive to the tumor cells
injected intraperitoneally than intravenously. Furthermore, it was demonstrated
that the most susceptible tissue in mice changes from the lung to the peritoneum with
. .Increasmg age.
Toxicity of sonized tUDlor ascites.
After application of sonic vibration to ascites for one minute, cells were ob-
served to aggregate, but only a small number of the cells were disrupted. Appli-
cation of the vibration for five one-minute periods resulted in almost complete
destruction of the cells, only cell fragments being demonstrated under the micro-
scope. Intraperitoneal injection of the fragments, however, sometimes induced
progressive tumors in adult mice, although the survival time of 6 mice dying of such
tumors was markedly prolonged, as table I shows.
Table 2. Challeage of Immunized Animals with Restored Ehrlich Tumor Cells.
CFl Ehrlich Fresh IV CFl Adult 22 16 (14.1) 4 (14.0)




CFl Ehrlich Sonized' ip CFl Adult 16 16 (15.9)
Newborn 23 23 (16.5)
C57BL Adult 6 2 (17.0) 2 (15.0)
Suckling 2 0
IV Newborn 3 2 (15.0) 0
ip 10 6 (16.0) 0
---------_. ------ -
CFl Lymphoid Fresh ip IC5:BL 14 days 12 6 (19.8) 2 (37.0)
7 days 12 10 (18.4) 2 (15.5)
I 2 days 12 12 (18.2)
--------












Age N? of I_ Deaths after challenge
at mIce at _
immuniz. first l-----rsi I 2nd I 3rd




* Numbers in parenthesis are avearge survival (in days) for mice that died.
After 6 to 8 one-minute periods of vibration, the suspension appeared non-
pathogenic to adult mice, but still toxic to young mice. Newborn receiving intra-
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peritoneal Injections of the suspension were eventually killed by ascitic tumors.
Among mice receiving such injections at the age of 2 or 3 days, many died of lung
tumors and some died of ascites. In this group of mice, deaths due to lung tumors
occurred within an average of 13 days after the injection, and deaths due to ascites
after an average of 18 days.
Intravenous injection of the sonized ascites into newborn mice was followed by
death due to shock. All treated mice became less active immediately after the
injection, and died within 12 hours. Similar injections into 2- or 3-day-old mice
were also followed by death due to shock, though some of the mice survived as long
as 4 days. Death due to shock also occurred in some of the mice after intraperito-
neal injection of the suspension.
Immunity in CFt mice pretreated with fresh or sonized tumor as-
cites f'rom other CFt :mice.
All CF1 mice surviving from previous Injection of sonized CFl ascites were
killed by the first challenge injection of the tumor. No prolonged survival time
was observed in these groups of mice; indeed, the pretreatment seemed to enhance
the growth of the tumor. In contrast, some of the mice pretreated by intravenous
injection offresh tumor cells showed resistance to one or more challenges. Evidently
induction of immunity in adult CFl mice by means of CFI tumor antigens is pos-
sible to some extent only with living tumor cells, and not with sonized cells or cell
fragments.
Immunity induced in C57BL mice by pretreatment with CFt tumor.
All C57BL mice surviving from intravenous injection of fresh CFl tumor
cells were resistant to challenge injections. In some mice, the first challenge in-
duced a slight accumulation of ascites, which appeared on the 7th day of the chal-
lenge, reached a maximum on the 12th day, and disappeared after that. No
accumulation of ascites was seen after the second or third injection.
About halfof the mice surviving from injection of sonized CF 1 tumor were resis-
tant to the first challenge. Some of the mice that were resistant to the first challenge
were killed by the second challenge.
Im:munity in C57BL mice pretreated with lymphoid cells from CFt
:mice.
Lymphoid cells from CF1 mice were also effective in furnishing C57BL mice
with immunity. Such pretreatment was almost fully effective for 14-day-olds, less
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effective for 7-day-olds, and ineffective for 2-day-olds. The survival time of the
mice dying in these three groups seemed to be prolonged to some extent, showing
induction of incomplete immunity.
DISCUSSION
Many studies have shown that induction of tumor immunity In mIce of the
strain in which the tumor originated was possible for newly induced tumors, but was
extremely difficult for spontaneous tumors. The difficulty has been considered to
be due to lack of antigenicity or to masked antigens in the tumors. Transplantation
of X-ray-inactivated tumor cells was successful in detecting the isoantigenicity of the
tumors (7, 8). X-irradiated tumor cells have also been used successfully for in-
duction of immunity to Ehrlich ascites tumor (4, 5). Irradiation is known to
reduce the activity of the tumor cells (9) and to induce the development of slow-
growing cells considered responsible for the induction of tumor immunity (5). It
is well known that strangulation or resection of tumors is able to induce immunity
in tumor-bearing animals. Immunity has sometimes been observed in animals
receiving inadequate implantations of tumors. Slow-growing cells may also play
a role in the induction of these latter types of immunity.
The experiments reported in this paper were successful in producing immunity
to Ehrlich tumor by pretreatment of homologus animals with fresh or sonized tumor
cells. Repeated applications of sonic vibration reduced the activity of tumor cells
markedly, but the sonized ascites still contained living cells, since injection of the
materials induced progressive ascites or lung tumors in newborn animals. Presuma-
bly the immunity induced after injection of sonized ascites may be attributed to
slow-growing cells. The immunity also was produced even in homologous animals
to some extent, when they were pretreated with a large quantity of fresh tumor cells
through an inadiquate route for transplantation of the tumor. These experiments
suggest importance of living tumor cells in the sensitizing materials. Why living
cells are indispensable to the acquisition of tumor immunity, whereas pretreatment
with dead cell materials enhances tumor growth (10), remains unexplained. It
should also be pointed out that the induced immunity may be relatively nonspecific
(11). These problems are analogous to those presented by some bacterial immuni-
ties.
In any event, injection of large amounts of living cells seems to be essential
to the induction of tumor immunity, and this principle was taken into account in
the present study through the use of tumor cells oflow virulence, obtained by means
of sonic vibration, or by administering the cells by an inadequate route, namely
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intravenous Injection in the case of adult mice. This study failed to demonstrate
iso-immunity in CF I mice, although the possibility of achieving such immunity
through the intravenous injection of tumor cells showed some promise. In contrast,
the iso-antigenicity of CFI tumors was established in C57BL mice, which exhibited
rather definite immunity after injection of fresh or sonized tumors. Pretreatment of
C57BL mice with large amounts of CFI lymphoid cells was also effective in inducing
tumor immunity, but not in very young mice. Presumably the nonspecific patho-
genicity of the Ehrlich tumor may be due to rapid growth rather than to lack of
isoantigenicity.
Furthermore, the present study has demonstrated a specific susceptibility of
young mice to the Ehrlich tumor. Newborn mice developed significant lung lesions
after either intravenous or intraperitoneal injection of the tumor. The high suscep-
tibility of the lung in the newborn may extend to other tumors.
SUMMARY
Homologous immunity to Ehrlich ascites tumor was induced In C57BL mIce
after treatment with CFI tumor or lymphoid cells. The induction of tumor
immunity was considered to result from long-lasting antigenicity in CFI cells of
low virulence. A possibility of producing iso-immunity in CFI mice was shown
to exist after intravenous injection of large amount of CFI tumor cells. Finally,
a high sensitivity to the Ehrlich tumor was demonstrated in the lungs of young mice.
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